PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17644511-1	2007	AIMS: This randomized controlled study was designed to determine whether oral coenzyme Q(10) (CoQ(10)) supplementation (100 mg tid) was able to improve extracellular superoxide dismutase (ecSOD) activity and endothelium-dependent (ED) vasodilation in patients with coronary artery disease (CAD).	coenzyme Q10	94-101	superoxide dismutase 3	Homo sapiens	152-186	
17644511-1	2007	AIMS: This randomized controlled study was designed to determine whether oral coenzyme Q(10) (CoQ(10)) supplementation (100 mg tid) was able to improve extracellular superoxide dismutase (ecSOD) activity and endothelium-dependent (ED) vasodilation in patients with coronary artery disease (CAD).	coenzyme Q10	94-101	superoxide dismutase 3	Homo sapiens	188-193	
17644511-10	2007	In particular, improvements elicited by CoQ(10) supplementation were remarkable in subjects presenting low initial endothelium-bound ecSOD and thus more prone to oxidative stress.	coenzyme Q10	40-47	superoxide dismutase 3	Homo sapiens	133-138	
17644511-11	2007	CONCLUSION: Improvements in the ED relaxation and endothelium-bound ecSOD activity might be related to CoQ(10) capability of enhancing endothelial functionality by counteracting nitric oxide oxidation.	coenzyme Q10	103-110	superoxide dismutase 3	Homo sapiens	68-73